View Older Stories View More Recent Stories

Mar 7, 2017 12:00PM Chardan Capital Maintains Buy Rating and $3.50 PT on 22nd Century Group (XXII) Ahead of Q4 Report
Mar 7, 2017 06:35AM Chardan Capital Maintains Buy Rating and $10 PT on Vuzix Corp. (VUZI); 'Strong Start to 2017 from M300 and Toshiba'
Mar 2, 2017 07:15AM Chardan Capital Reiterates Buy Rating and $11.50 PT on ORBCOMM (ORBC); 'Strong Backlog and Robust Pipeline'
Mar 2, 2017 07:02AM Teladoc (TDOC) PT Raised to $28 at Chardan Capital Markets Following 4Q Top-Line and Bottom-Line Beats
Mar 2, 2017 06:02AM La Jolla Pharma (LJPC) PT Raised to $90 at Chardan Capital Markets Following Robust LJPC-501 Phase 3 Topline Results
Feb 28, 2017 06:03AM Chardan Capital Maintains Hold Rating and $1.50 PT on Novavax (NVAX) Following 4Q Report; New RSV F Clinical Data is Next Catalyst
Feb 24, 2017 07:27AM Chardan Capital Markets Upgrades Globalstar (GSAT) to Buy
Feb 23, 2017 06:53AM Chardan Capital Markets Starts OncoCyte Corp (OCX) at Buy
Feb 21, 2017 08:12AM Chardan Capital Markets Reiterates Buy on NICE Systems (NICE) Following 4Q Report
Feb 21, 2017 06:58AM Chardan Capital Reiterates Neutral Rating and $35 PT on DigitalGlobe (DGI) Following Takeover Reports
Feb 21, 2017 06:27AM Teladoc (TDOC): More Confident After Management Meetings - Chardan
Feb 15, 2017 04:05PM BioTime, Inc. Announces Closing of Public Offering of Common Stock
Feb 14, 2017 08:55AM Chardan Capital Markets Remains Bullish on NICE Systems (NICE) Ahead of 4Q Report
Feb 14, 2017 08:29AM Chardan Capital Markets Upgrades Sage Therapeutics (SAGE) to Neutral
Feb 13, 2017 06:52AM Chardan Capital Markets Reiterates Buy on HealthEquity (HQY) Following Investor Call
Feb 10, 2017 09:03AM BioTime (BTX) Prices 6.5M Common Stock Offering at $2.70/Share
Feb 10, 2017 09:02AM BioTime, Inc. Announces Pricing of Public Offering of Common Stock
Feb 7, 2017 08:08AM HealthEquity (HQY): Strong Preannouncement With Guidance In Line - Chardan
Feb 3, 2017 02:55PM MYOS RENS Tech (MYOS) Reports $2.13M Registered Direct Offering of Common Stock
Feb 3, 2017 02:54PM MYOS RENS Technology Inc. Announces $2,125,000 Registered Direct Offering
Feb 3, 2017 09:29AM Pre-Open Movers 02/03: (PXLW) (DATA) (PTN) Higher; (DECK) (IDXG) (FEYE) (GPRO) (AMZN) Lower (more...)
Feb 3, 2017 04:32AM Chardan Capital Markets Downgrades Clovis Oncology (CLVS) to Sell
Feb 1, 2017 06:24AM Chardan Capital Markets Starts Social Reality (SRAX) at Buy, $9 PT
Jan 30, 2017 10:19AM uniQure (QURE) Breakthrough Therapy Designation an 'Important Positive' - Chardan Capital Markets
Jan 30, 2017 07:13AM Emergent BioSolutions (EBS): 3 Key Points From NDR - Chardan
Jan 27, 2017 08:36AM KeyW Holding (KEYW) 8.5M Share Offering Prices at $10.50
Jan 27, 2017 08:30AM KeyW Announces Pricing of Public Offering of Common Stock
Jan 26, 2017 05:07PM KeyW (KEYW) Announces 8.5M Public Offering of Common Stock
Jan 26, 2017 05:06PM KeyW Announces Public Offering of Common Stock
Jan 26, 2017 10:01AM AveXis (AVXS) Ramps 11% on Bullish Analyst Call, $100 PT
Jan 26, 2017 09:47AM AveXis (AVXS) PT Raised to $100 at Chardan Capital Markets
Jan 24, 2017 08:29AM La Jolla Pharma (LJPC) a Top Pick at Chardan Capital Markets Into Data
Jan 17, 2017 08:38AM PlacementTracker Publishes 2016 Private Placement Market League Tables
Jan 11, 2017 08:14AM NICE Systems (NICE): Raising PT After Acquisition Closes - Chardan
Jan 9, 2017 06:56AM Alnylam Pharmaceuticals (ALNY) PT Raised 41% at Chardan Capital Markets to $97
Jan 6, 2017 06:39AM Medicines Co. (MDCO): Top Pick for 2017 - Chardan
Jan 6, 2017 05:51AM Chardan Capital Markets Starts Benefitfocus (BNFT) at Buy, $36 PT
Jan 5, 2017 12:56PM Chardan Capital Weighs in on 22nd Century Group (XXII) as FDA Responds to MRTP Application
Jan 5, 2017 07:03AM Microbot Medical (MBOT) to Sell 700K Shares for $3.5M in Direct Offering
Jan 5, 2017 07:00AM Microbot Medical Inc. Announces $3.5 Million Registered Direct Offering
Jan 4, 2017 10:35AM Social Reality (SRAX) Announces $4M Direct Offering
Jan 4, 2017 10:34AM Social Reality Announces Offering for $4 Million
Dec 27, 2016 09:38AM Spinraza Label Suggests AveXis (AVXS) AVXS-101 Should Be The Superior Product - Chardan Capital Markets
Dec 27, 2016 06:32AM GlobalStar (GSAT): FCC Approves TLPS - Chardan Capital Markets
Dec 20, 2016 09:32AM Northwest Biotherapeutics (NWBO) to Sell 28.6M Shares at $0.35/Share
Dec 20, 2016 09:29AM NW BIO ANNOUNCES A REGISTERED DIRECT OFFERING OF $10.0 MILLION WITH INSTITUTIONAL INVESTORS
Dec 20, 2016 07:31AM Chardan Capital Markets Upgrades Clovis Oncology (CLVS) to Neutral
Dec 19, 2016 04:05PM Origo Acquisition Corporation and Aina Le’a, Inc. Agree to Business Combination
Dec 16, 2016 06:24AM Chardan Capital Markets Downgrades iPass Inc. (IPAS) to Neutral
Dec 15, 2016 06:29AM Chardan Capital Markets Upgrades Profire Energy (PFIE) to Buy
View More Recent Stories View Older Stories